Platysmaplasty Treatment Market Report 2026

Platysmaplasty Treatment Market Report 2026
Global Outlook – By Procedure (Surgical Procedure, Non Surgical Procedure), By Gender (Male, Female), By End-Use (Cosmetic Surgery Clinics, Hospitals ) - Market Size, Trends, And Global Forecast 2026-2035
Platysmaplasty Treatment Market Overview
• Platysmaplasty Treatment market size has reached to $1.16 billion in 2025 • Expected to grow to $1.65 billion in 2030 at a compound annual growth rate (CAGR) of 7.1% • Growth Driver: Increasing Demand For Cosmetic Procedures On The Platysmaplasty Treatment Market • Market Trend: Renuvion Technology And The Apyx One Consoledures • North America was the largest region in 2025.What Is Covered Under Platysmaplasty Treatment Market?
Platysmaplasty treatment is a surgical procedure aimed at improving the appearance of the neck by tightening the muscles and reducing excess skin. It specifically targets the platysma muscle, which can become lax over time due to aging or weight loss, leading to the development of neck bands or a turkey-wattle appearance. The main types of procedures in platysmaplasty treatments are surgical procedures and non-surgical procedures. Surgical platysmaplasty involves invasive techniques where incisions are made in the neck area to access and tighten the platysma muscle directly. The treatments are used for gender, such as male and female, in cosmetic surgery clinics and hospitals.
What Is The Platysmaplasty Treatment Market Size and Share 2026?
The platysmaplasty treatment market size has grown strongly in recent years. It will grow from $1.16 billion in 2025 to $1.26 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising awareness of cosmetic enhancement options, growth in elective cosmetic surgeries, increased disposable income in urban populations, expansion of specialized cosmetic clinics, advancements in surgical techniques.What Is The Platysmaplasty Treatment Market Growth Forecast?
The platysmaplasty treatment market size is expected to see strong growth in the next few years. It will grow to $1.65 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing demand for non-invasive aesthetic treatments, growth in medical tourism for cosmetic procedures, rising adoption of energy-based devices, expanding male aesthetic treatment segment, continuous innovation in cosmetic surgery techniques. Major trends in the forecast period include increasing demand for minimally invasive neck rejuvenation, rising adoption of non-surgical platysmaplasty techniques, growing preference for laser-assisted procedures, expansion of aesthetic surgery among aging populations, enhanced focus on shorter recovery times.Global Platysmaplasty Treatment Market Segmentation
1) By Procedure: Surgical Procedure, Non Surgical Procedure 2) By Gender: Male, Female 3) By End-Use: Cosmetic Surgery Clinics, Hospitals Subsegments: 1) By Surgical Procedure: Traditional Neck Lift Surgery, Laser-Assisted Platysmaplasty, Endoscopic Platysmaplasty 2) By Non-Surgical Procedure: Botox Or Dysport Injections, Thread Lifting, UltherapyWhat Is The Driver Of The Platysmaplasty Treatment Market?
The increasing demand for cosmetic procedures is expected to propel the growth of the platysmaplasty treatment market. Cosmetic procedures encompass a range of surgical and non-surgical interventions to enhance or alter a person's physical appearance for aesthetic purposes. The increasing demand for cosmetic procedures is driven by societal emphasis on appearance, advancements in medical technology, and growing acceptance of aesthetic enhancement to boost self-confidence and improve overall well-being. Platysmaplasty treatment is used in cosmetic procedures to address sagging or aging skin in the neck area, providing patients with a rejuvenated and youthful appearance. For instance, in July 2025, the International Society of Aesthetic Plastic Surgery, a US-based non-profit organization, reported that total surgical procedures increased from 14,986,982 in 2022 to 15,813,353 in 2023. Therefore, increasing demand for cosmetic procedures will drive the growth of the platysmaplasty treatment industry.Key Players In The Global Platysmaplasty Treatment Market
Major companies operating in the platysmaplasty treatment market are Mayo Clinic, Cleveland Clinic Foundation, Duke Health, Lumenis Ltd., Cutera Inc., Lutronic Corporation, Sinclair Pharma plc, Candela Corporation, Merz Aesthetics, Piedmont Plastic Surgery & Dermatology, Quanta System S.p.A., Long Island Plastic Surgical Group, Westlake Dermatology & Cosmetic Surgery, Allergan Aesthetics, The Esthetic Clinics, Cadogan Clinic, BTL Aesthetics Inc., Avenue Plastic Surgery, Dr. Cat Plastic Surgery, Los Angeles Plastic Surgery Clinic, Nazarian Plastic Surgery, The Istanbul Aesthetic Center, Marina Plastic Surgery, Elite Plastic SurgeryGlobal Platysmaplasty Treatment Market Trends and Insights
Major companies operating in the platysmaplasty treatment market focus on innovative technologies such as Renuvion technology to enhance surgical outcomes, reduce recovery times, and improve patient satisfaction by offering minimally invasive solutions promoting skin tightening and contouring. Renuvion technology combines helium plasma and radiofrequency energy to create a gentle, controlled heating effect on the skin, promoting tightening and rejuvenation. For instance, in January 2023, Apyx Medical Corporation, a US-based medical equipment manufacturer, launched Apyx One Console, a significant advancement in the cosmetic surgical market. The console employs both radiofrequency energy and helium plasma, which are crucial for cutting, coagulating, and ablating soft tissue during surgical procedures. The Apyx One Console is not only a state-of-the-art device but also a critical asset within the platysmaplasty treatment market, enhancing surgical capabilities and patient satisfaction through its innovative technology.What Are Latest Mergers And Acquisitions In The Platysmaplasty Treatment Market?
In April 2024, Ascend Plastic Surgery Partners, a U.S.–based plastic surgery platform, acquired Ponte Vedra Plastic Surgery for an undisclosed amount. Through this acquisition, Ascend aims to expand its neck lift and facial rejuvenation services by integrating Ponte Vedra’s surgical capabilities and broadening its portfolio of cosmetic and reconstructive procedures. Ponte Vedra Plastic Surgery is a U.S.-based clinic that provides a range of cosmetic and plastic surgery services, including neck lifts, facelifts, and body contouring procedures.Regional Outlook
North America was the largest region in the platysmaplasty treatment market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Platysmaplasty Treatment Market?
The platysmaplasty treatment market consists of revenues earned by entities by providing services such as consultation and assessment, postoperative care, skincare, and maintenance. The market value includes the value of related goods sold by the service provider or included within the service offering. The platysmaplasty treatment market also includes sales of surgical instruments, equipment, implants, materials, topical treatments, and compression garments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Platysmaplasty Treatment Market Report 2026?
The platysmaplasty treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the platysmaplasty treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Platysmaplasty Treatment Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.26 billion |
| Revenue Forecast In 2035 | $1.65 billion |
| Growth Rate | CAGR of 8.1% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Procedure, Gender, End-Use |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Mayo Clinic, Cleveland Clinic Foundation, Duke Health, Lumenis Ltd., Cutera Inc., Lutronic Corporation, Sinclair Pharma plc, Candela Corporation, Merz Aesthetics, Piedmont Plastic Surgery & Dermatology, Quanta System S.p.A., Long Island Plastic Surgical Group, Westlake Dermatology & Cosmetic Surgery, Allergan Aesthetics, The Esthetic Clinics, Cadogan Clinic, BTL Aesthetics Inc., Avenue Plastic Surgery, Dr. Cat Plastic Surgery, Los Angeles Plastic Surgery Clinic, Nazarian Plastic Surgery, The Istanbul Aesthetic Center, Marina Plastic Surgery, Elite Plastic Surgery |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Platysmaplasty Treatment market was valued at $1.16 billion in 2025, increased to $1.26 billion in 2026, and is projected to reach $1.65 billion by 2030.
The global Platysmaplasty Treatment market is expected to grow at a CAGR of 7.1% from 2026 to 2035 to reach $1.65 billion by 2035.
Some Key Players in the Platysmaplasty Treatment market Include, Mayo Clinic, Cleveland Clinic Foundation, Duke Health, Lumenis Ltd., Cutera Inc., Lutronic Corporation, Sinclair Pharma plc, Candela Corporation, Merz Aesthetics, Piedmont Plastic Surgery & Dermatology, Quanta System S.p.A., Long Island Plastic Surgical Group, Westlake Dermatology & Cosmetic Surgery, Allergan Aesthetics, The Esthetic Clinics, Cadogan Clinic, BTL Aesthetics Inc., Avenue Plastic Surgery, Dr. Cat Plastic Surgery, Los Angeles Plastic Surgery Clinic, Nazarian Plastic Surgery, The Istanbul Aesthetic Center, Marina Plastic Surgery, Elite Plastic Surgery .
Major trend in this market includes: Renuvion Technology And The Apyx One Consoledures. For further insights on this market.
Request for SampleNorth America was the largest region in the platysmaplasty treatment market in 2025. The regions covered in the platysmaplasty treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
